Hong Kong Stock Connect innovative drugs opened higher again, with 520880 rising three consecutive days! Yingneng Bio-B and InSilico Intelligent led gains of over 4%

As of 09:37 on 2026-03-31, the Huabao Hang Seng Stock Connect Innovative Drug ETF (520880) in the Hong Kong Stock Connect market is up 0.80%. Its latest price is 0.507 yuan, with a turnover rate of 2.80%.

The Huabao Hang Seng Stock Connect Innovative Drug ETF (520880) closely tracks the Hang Seng Stock Connect Innovative Drug Select Index. Among the index constituent stocks, BeiGene is up 2.28%, Innovent Biologics is up 1%, and CSPC Pharmaceutical is up 0.86%, while Sanhome Pharmaceuticals is down 1.15% and CanSino Biologics is down 1.05%. This index is designed to reflect the performance of Hong Kong-listed companies whose businesses are related to the research, development, and production of innovative drugs and that can be traded via the Stock Connect. Base date: December 31, 2020. Base points: 3000.

According to the data, the latest size of the Huabao Hang Seng Stock Connect Innovative Drug ETF (520880) reaches 2.306 billion yuan, with the latest outstanding units at 4.610 billion units. The fund size has increased by 0.17 billion yuan compared with one month earlier.

Huabao Hang Seng Stock Connect Innovative Drug ETF (520880), OTC fund-to-fund (025220.OF,025221.OF)

(Editor: Dong Pingping)

     【Disclaimer】This article only represents the author’s personal views and is not related to Hexun. Hexun does not provide any express or implied guarantee regarding the accuracy, reliability, or completeness of the statements, views, and judgments contained in the article. Readers are advised to use this information only as a reference and assume all responsibility themselves. Email: news_center@staff.hexun.com

Report